Efficacy of antibody-based therapies to treat Alzheimer's disease: just a matter of timing? [electronic resource]
- Experimental gerontology Sep 2014
- 104-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-6815
10.1016/j.exger.2014.05.002 doi
Alzheimer Disease--drug therapy Amyloid beta-Peptides--immunology Antibodies--therapeutic use Antibodies, Monoclonal, Humanized--therapeutic use Clinical Trials, Phase III as Topic Humans Immunotherapy